Easing the burden on Europe's medicines agencies
This article was originally published in Scrip
The global economic crisis has placed many European industries under financial pressure. To date, however, the pharmaceutical industry has appeared to be remarkably resilient for one simple reason: society demands health. Yet, while the industry has maintained a sense of imperviousness, some of the EU member state medicines agencies are beginning to buckle under the pressure of the economic downturn, coupled with the increasing legislative demands that emanate from Brussels.